Flipboard News DeskA U.S. Food and Drug Administration panel has voted against approving the use of MDMA in conjunction with therapy to treat post-traumatic stress disorder. MDMA, more commonly known as Ecstasy, is among a slate of psychoactive street drugs that have seen increased advocacy and interest for their potential therapeutic uses. The FDA panelists cited gaps in data and accusations of therapist misconduct during the studies in their decision. Read more from CBS News.
０７６萌ＳＮＳ is a social network, courtesy of ０７６. It runs on GNU social, version 2.0.2-beta0, available under the GNU Affero General Public License.
All ０７６萌ＳＮＳ content and data are available under the Creative Commons Attribution 3.0 license.